MEIJI SEIKA PHARMATECH CO., LTD — Famotidine Importer Profile
Pharmaceutical Importer · #12 buyer for Famotidine · $534.1K import value · 18 shipments · JAPAN · DGFT Verified
MEIJI SEIKA PHARMATECH CO., LTD is the #12 importer of Famotidine from India with $534.1K in import value and 18 verified shipments. MEIJI SEIKA PHARMATECH CO., LTD holds a 1.4% market share in Famotidine imports based in JAPAN. The company sources from 1 verified supplier across 14 formulations shipped to 1 country.
MEIJI SEIKA PHARMATECH CO., LTD — Famotidine Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Famotidine to MEIJI SEIKA PHARMATECH CO., LTD?
Verified from 18 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MEDREICH LIMITED | $534.1K | 18 | 100.0% |
MEIJI SEIKA PHARMATECH CO., LTD sources Famotidine from 1 verified Indian supplier based on 18 customs records. The primary supplier is MEDREICH LIMITED accounting for 100.0% of imports.
How Does MEIJI SEIKA PHARMATECH CO., LTD Compare to Nearest Famotidine Importers?
Buyers ranked immediately above and below #12 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | TIME-CAP LABS, | UNITED STATES | $828.3K | 65 | $12.7K |
| 11 | CAMBER PHARMACEUTICALS INC | UNITED STATES | $774.1K | 66 | $11.7K |
| 12 | MEIJI SEIKA PHARMATECH CO., LTD ★ | JAPAN | $600.0K | 12 | $50.0K |
| 13 | XXROBXXDO XXARMXXUSAXX INX | UNITED STATES | $550.0K | 11 | $50.0K |
| 5 | XXROHXXLTHXXLC | UNITED STATES | $400.0K | 8 | $50.0K |
MEIJI SEIKA PHARMATECH CO., LTD ranks #12 among 302 Famotidine importers from India. Average shipment value of $50.0K compared to the market average of $62.3K. The closest competitors by value are TIME-CAP LABS, and CAMBER PHARMACEUTICALS INC.
Where Does MEIJI SEIKA PHARMATECH CO., LTD Import Famotidine To?
Destination countries from 18 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| JAPAN | $534.1K | 18 | 100.0% |
MEIJI SEIKA PHARMATECH CO., LTD imports Famotidine to 1 country. The primary destination is JAPAN receiving 100.0% of shipments worth $534.1K.
What Famotidine Formulations Does MEIJI SEIKA PHARMATECH CO., LTD Import?
| Formulation | Value | Shipments |
|---|---|---|
| FAMOTIDINE 20MG TABLETS PO NO MM 155 PACK SIZE 55556 NO QTY 231 974 | $100.0K | 2 |
| FAMOTIDINE 20MG TABLETS, PO NO.MM-161 DT | $50.0K | 1 |
| FAMOTIDINE 20MG TABLETS PO NO.MM-163 DTD 29.05.2023 PACK SIZE:55556 NO QTY:79.579 | $50.0K | 1 |
| FAMOTIDINE 10MG TABLETS, PO NO. MM-167 DTD 30.08.2023, PACK SIZE:62500 NO, QTY:78.877 | $50.0K | 1 |
| FAMOTIDINE 20MG TABLETS, PO NO. MM-165 DTD 21.07.2023, PACK SIZE:55556 NO, QTY:157.704 | $50.0K | 1 |
| FAMOTIDINE 20MG TABLETS , PACK SIZE:55556 NO , QTY:158.943 | $50.0K | 1 |
| FAMOTIDINE 20MG TABLETS, PACK SIZE:55556 NO, QTY:77.860 | $50.0K | 1 |
| FAMOTIDINE 10MG TABLETS , PACK SIZE:62500 NO , QTY:77.880 | $50.0K | 1 |
| FAMOTIDINE 20MG TABLETS, PACK SIZE:55556NO , QTY:79.035 | $50.0K | 1 |
| FAMOTIDINE OD TABLETS 10 MG, PACK SIZE:62500, QTY:36.486 | $16.5K | 1 |
MEIJI SEIKA PHARMATECH CO., LTD imports 14 distinct Famotidine formulations from India. The top formulation is FAMOTIDINE 20MG TABLETS PO NO MM 155 PACK SIZE 55556 NO QTY with 2 shipments worth $100.0K.
Regulatory Requirements: Importing Famotidine into Japan
What MEIJI SEIKA PHARMATECH CO., LTD and other importers must comply with to import Famotidine from India
Regulatory Authority
Pharmaceuticals and Medical Devices Agency (PMDA)
Approval Process for Generic Famotidine
Generic Drug Application under Japan Pharmaceutical Affairs Act. Requires dissolution and bioequivalence studies per PMDA guidelines. Japanese data bridging often required.
Typical timeline: 12–24 months
GMP Requirements
Japanese GMP (J-GMP) compliance; PMDA on-site inspection of manufacturing facility
Import Licence & Documentation
Marketing Authorization Holder (MAH) must be a Japanese entity; Foreign Manufacturer Registration (Accreditation) required
Labeling & Packaging
Japanese language labeling mandatory; Japanese Pharmacopoeia compliance
Note: Japan requires Yen-denominated pricing approval (NHI drug price listing). Stability data under ICH Zone IVb conditions.
Regulatory information is provided for general reference based on publicly available PMDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with PMDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Famotidine from India and How Much Does MEIJI SEIKA PHARMATECH CO., LTD Import?
India exported $18.8M worth of Famotidine through 2,750 shipments from 152 suppliers to 66 countries, serving 302 buyers globally. MEIJI SEIKA PHARMATECH CO., LTD imports $534.1K of this total, accounting for 1.4% of India's Famotidine exports with 18 shipments from JAPAN. This is verified from 18 customs shipment records covering 14 distinct formulations.
What Is the Average Order Value for MEIJI SEIKA PHARMATECH CO., LTD's Famotidine Imports?
MEIJI SEIKA PHARMATECH CO., LTD's average Famotidine order value is $29.7K per consignment, based on 18 shipments totaling $534.1K. MEIJI SEIKA PHARMATECH CO., LTD is based in JAPAN and ranks #12 among all Famotidine importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Famotidine to MEIJI SEIKA PHARMATECH CO., LTD?
MEIJI SEIKA PHARMATECH CO., LTD sources Famotidine from 1 verified Indian supplier: MEDREICH LIMITED ($534.1K, 100.0%). This is based on 18 customs records.
How Does MEIJI SEIKA PHARMATECH CO., LTD Compare to Other Famotidine Importers?
MEIJI SEIKA PHARMATECH CO., LTD ranks #12 among 302 Famotidine importers from India with a 1.4% market share. The top 3 importers are MYLAN INSTITUTIONAL INC 2898 ($5.0M), J. KNIPPER & COMPANY ($3.2M), MYLAN INSTITUTIONAL INC ($2.6M). MEIJI SEIKA PHARMATECH CO., LTD processed 18 shipments from JAPAN.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Famotidine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Famotidine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MEIJI SEIKA PHARMATECH CO., LTD matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MEIJI SEIKA PHARMATECH CO., LTD's capped import value divided by total capped export value for Famotidine across all Indian exporters.
- 5.Verified Records: This page is backed by 18 individual customs records matching MEIJI SEIKA PHARMATECH CO., LTD importing Famotidine, covering 14 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 66+ countries, 302+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Famotidine Import Data for MEIJI SEIKA PHARMATECH CO., LTD
Access order-level details, pricing data, supplier connections, and competitive analysis for MEIJI SEIKA PHARMATECH CO., LTD's Famotidine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MEIJI SEIKA PHARMATECH CO., LTD
Company Profile
Multiple products · $0 total trade · Multiple categories
MEIJI SEIKA PHARMATECH CO., LTD × Famotidine
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MEIJI SEIKA PHARMATECH CO., LTD.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Famotidine. For current order-level data, contact TransData Nexus.